ALLMedicine™ Scleritis Center

May 17th, 2022 - Report the case of a patient with a history of central retinal artery occlusion in her right eye and amaurosis fugax associated with acute ischemic changes in her left eye related to a prothrombin G20210A gene variant, in which OCT-A was used as a...

May 13th, 2022 - Uveitis refers to a large group of intraocular inflammatory diseases that can cause devastating visual loss in adults and children. This study establishes a clinical database and biospecimen repository for the identification of novel factors relev...

May 12th, 2022 - Ophthalmic conditions including anterior uveitis (AU), episcleritis and scleritis may occur in association with the inflammatory bowel diseases (IBD) as ophthalmic extraintestinal manifestations. The aim of this study was to assess the risk of a l...

May 6th, 2022 - To estimate the incidence of scleritis in Lyme disease and report clinical features. Incidence rate estimate and case series METHODS: Data were collected from an electronic medical record on patients with scleritis resenting to the Wilmer Eye Inst...

Apr 29th, 2022 - Conjunctival lymphomas are rare entities and may present with non-specific ocular signs that resemble inflammation. It may mimic common ocular pathologies, leading to a delay in its diagnosis and treatment. The treatment options of conjunctival ly...

Dec 24th, 2013 - To provide recommendations for the use of anti-tumor necrosis factor α (TNF-α) biologic agents in patients with ocular inflammatory disorders. Ocular inflammatory diseases remain a leading cause of vision loss worldwide. Anti-TNF-α agents are used...

May 13th, 2022 - Uveitis refers to a large group of intraocular inflammatory diseases that can cause devastating visual loss in adults and children. This study establishes a clinical database and biospecimen repository for the identification of novel factors relev...

Apr 12th, 2022 - For the purposes of determining the prevalence of ocular complications in inflammatory rheumatic diseases, the following search terms were used: conjunctivitis, keratoconjunctivitis sicca, xerophthalmia, uveitis, eye hemorrhage, optic neuritis, pa...

Mar 24th, 2022 - BACKGROUND AND RATIONALE 1.1 General Introduction Ocular surface disease, especially dry eye and scleritis, commonly affects patients with autoimmune diseases. Ocular surface immune cells are increased in autoimmune disease; however the full subse...

Jan 21st, 2022 - The AIDA registry service is based on REDCap (Research Electronic Data Capture, project-redcap.org), a secure web application for building and managing online surveys and databases, designed to support data capture for research studies. The platfo...

Sep 1st, 2020 - Periodontitis is a chronic low-grade bacterial infection of supporting tissue of teeth. Chronic periodontitis is often non symptomatic. Inflammation is located usually in deepened periodontal pockets (> 4mm or >6mm) and it leads to alveolar bone l...

Mar 22nd, 2021 - NEW YORK (Reuters Health) - The incidence of scleritis has fallen by about a third in the United Kingdom over roughly the past two decades, likely due to improvements in the management of immune-related diseases, researchers report. "Scleritis is ...

Feb 19th, 2021 - A new study published in the journal  Eye  suggests that one-third of patients with uveitis in the UK receive excess systemic corticosteroids (CS), and there is a scope to reduce excess prescribing in a quarter of them. CS are widely prescribed fo...

Jan 22nd, 2021 - Test yourself with this question from Osmosis.org and see how you stack up against your peers! A 26-year-old woman is evaluated for chronic eye pain and eye redness. She also reports some photophobia and says that her pain is not significantly cha...

Jan 15th, 2021 - NEW YORK (Reuters Health) - Patients with secondary Sjogren's syndrome (SS) are at increased risk of corneal complications compared to those with primary SS, and eyes with scleritis are at especially high risk of vision-threatening complications, ...

Dec 20th, 2020 - Hope Rugo, MD With tremendous advances and the accelerated approval of atezolizumab (Tecentriq) plus nab-paclitaxel (Abraxane) for patients with unresectable locally advanced or metastatic PD-L1—positive triple-negative breast cancer, provider ed...